Development of a vaccine against the synthetic opioid U-47700
Opioid use disorders and overdose have become a major public health concern in recent years. U-47700, a New psychoactive substances (NPS) opioid, also known as "pinky" or "pink" has been identified as a new threat in the drug supply because of its potency and abuse potential. Con...
Saved in:
Main Authors: | Hyeri Park (Author), Mingliang Lin (Author), Jian Zhou (Author), Lisa M. Eubanks (Author), Bin Zhou (Author), Kim D. Janda (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
First Case in Italy of Fatal Intoxication Involving the New Opioid U-47700
by: Enrico Gerace, et al.
Published: (2018) -
U-47700 - Incidence of a novel psychoactive substance in a series of medical examiner cases in Oakland County, MI
by: Lauren Aiello, et al.
Published: (2020) -
Postmortem Toxicology of New Synthetic Opioids
by: Marta Concheiro, et al.
Published: (2018) -
Drug Interactions With New Synthetic Opioids
by: Clara Pérez-Mañá, et al.
Published: (2018) -
Development and evaluation of candidate subunit vaccine against botulinum neurotoxin serotype B
by: Dan-Yang Shi, et al.
Published: (2019)